-
摘要: 心力衰竭是各种心血管疾病发展至终末期的临床综合征,有着较高的发病率和病死率。随着各项治疗技术的发展,射血分数降低型心力衰竭(HFrEF)患者左心室射血分数的恢复成为了可能,于是出现了射血分数改善型心力衰竭(HFrecEF)这一新的临床类型,但目前相关研究甚少,本研究主要对这一新的临床类型的临床特点、病理生理学、治疗及预后作一综述。Abstract: Heart failure is the terminal stage of various cardiovascular diseases,which is a clinical syndrome with high morbidity and mortality.With the development of various treatment techniques,it is possible to recover left ventricular ejection fraction in patients with heart failure with reduced ejection fraction.There is a new type of heart failure named heart failure with recovered ejection fraction(HFrecEF).However,few studies have been made to investigate the clinical profile of HFrecEF.Therefore,this paper is sought to review the clinical characteristics,pathophysiological mechanism,treatment and prognosis of this new type of heart failure.
-
-
[1] Ngu JMC,Ruel M,Sun LY.Left ventricular function recovery after revascularization:comparative effects of percutaneous coronary intervention and coronary artery bypass grafting[J].Curr Opin Cardiol,2018,33(6):633-637.
[2] 中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志,2018,46(10):760-789.
[3] Punnoose LR,Givertz MM,Lewis EF,et al.Heart failure with recovered ejection fraction:a distinct clinical entity[J].J Card Fail,2011,17(7):527-532.
[4] Merlo M,Pyxaras SA,Pinamonti B,et al.Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment[J].J Am Coll Cardiol,2011,57(13):1468-1476.
[5] Lupón J,Díez-López C,de Antonio M,et al.Recovered heart failure with reduced ejection fraction and outcomes:a prospective study[J].Eur J Heart Fail,2017,19(12):1615-1623.
[6] Yancy CW,Jessup M,Bozkurt B,et al.2013 ACCF/AHA guideline for the management of heart failure:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol,2013,62(16):e147-239.
[7] Basuray A,French B,Ky B,et al.Heart failure with recovered ejection fraction:clinical description,biomarkers,and outcomes[J].Circulation,2014,129(23):2380-2387.
[8] Swat SA,Cohen D,Shah SJ,et al.Baseline Longitudinal Strain Predicts Recovery of Left Ventricular Ejection Fraction in Hospitalized Patients With Nonischemic Cardiomyopathy[J].J Am Heart Assoc,2018,7(20):e09841.
[9] Adamo L,Perry A,Novak E,et al.Abnormal Global Longitudinal Strain Predicts Future Deterioration of Left Ventricular Function in Heart Failure Patients With a Recovered Left Ventricular Ejection Fraction[J].Circ Heart Fail,2017,10(6).pii:e003788.
[10] Mann DL,Barger PM,Burkhoff D.Myocardial recovery and the failing heart:myth,magic,or molecular target?[J].J Am Coll Cardiol,2012,60(24):2465-2472.
[11] Kuttab JS,Kiernan MS,Vest AR.Epidemiology of "Heart Failure with Recovered Ejection Fraction":What do we do After Recovery?[J].Curr Heart Fail Rep,2015,12(6):360-366.
[12] Nijst P,Martens P,Mullens W.Heart Failure with Myocardial Recovery-The Patient Whose Heart Failure Has Improved:What Next?[J].Prog Cardiovasc Dis,2017,60(2):226-236.
[13] Basuray A,Fang JC.Management of Patients With Recovered Systolic Function[J].Prog Cardiovasc Dis,2016,58(4):434-443.
[14] Roberts AM,Ware JS,Herman DS,et al.Integrated allelic,transcriptional,and phenomic dissection of the cardiac effects of titin truncations in health and disease[J].Sci Transl Med,2015,7(270):270ra6.
[15] Felkin LE,Walsh R,Ware JS,et al.Recovery of Cardiac Function in Cardiomyopathy Caused by Titin Truncation[J].JAMA Cardiol,2016,1(2):234-235.
[16] McMurray JJ,Packer M,Desai AS,et al.Angiotensin-neprilysin inhibition versus enalapril in heart failure[J].N Engl J Med,2014,371(11):993-1004.
[17] Velazquez EJ,Morrow DA,DeVore AD,et al.Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure[J].N Engl J Med,2019,380(6):539-548.
[18] 黄琨,马威,郑川燕,等.伊伐布雷定治疗中重度慢性心力衰竭伴窦性心动过速的临床研究[J].临床心血管病杂志,2017,33(9):841-845.
[19] Liang Y,AUID-Oho,Wang Q,et al.Cessation of pacing in super-responders of cardiac resynchronization therapy:A randomized controlled trial[J].J Cardiovasc Electrophysiol,2018,29(11):1548-1555.
[20] Abdelrahman M,Subzposh FA,Beer D,et al.Clinical Outcomes of His Bundle Pacing Compared to Right Ventricular Pacing[J].J Am Coll Cardiol,2018,71(20):2319-2330.
[21] Prabhu S,Taylor AJ,Costello BT,et al.Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction:The CAMERA-MRI Study[J].J Am Coll Cardiol,2017,70(16):1949-1961.
[22] Klein P,Agostoni P,van Boven WJ,et al.Transcatheter and minimally invasive surgical left ventricular reconstruction for the treatment of ischaemic cardiomyopathy:preliminary resultsdagger[J].Interact Cardiovasc Thorac Surg,2019,28(3):441-446.
[23] Mehra MR,Uriel N,Naka Y,et al.A Fully Magnetically Levitated Left Ventricular Assist Device-Final Report[J].N Engl J Med,2019,380(17):1618-1627.
[24] Stone GW,Lindenfeld J,Abraham WT,et al.Transcatheter Mitral-Valve Repair in Patients with Heart Failure[J].N Engl J Med,2019,380(20):1980-1981.
[25] Ismail H,McFarlane JR,Nojoumian AH,et al.Clinical outcomes and cardiovascular responses to different exercise training intensities in patients with heart failure:a systematic review and meta-analysis[J].JACC Heart Fail,2013,1(6):514-522.
[26] Ghimire A,Fine N,Ezekowitz JA,et al.Frequency,predictors,and prognosis of ejection fraction improvement in heart failure:an echocardiogram-based registry study[J].Eur Heart J,2019,40(26):2110-2117.
[27] Halliday BP,Wassall R,Lota AS,et al.Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF):an open-label,pilot,randomised trial[J].Lancet,2019,393(10166):61-73.
[28] Moon J,Ko YG,Chung N,et al.Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy[J].Can J Cardiol,2009,25(5):e147-150.
[29] Gupta A,Goyal P,Bahl A.Frequency of recovery and relapse in patients with nonischemic dilated cardiomyopathy on guideline-directed medical therapy[J].Am J Cardiol,2014,114(6):883-889.
[30] Park JS,Kim JW,Seo KW,et al.Recurrence of left ventricular dysfunction in patients with restored idiopathic dilated cardiomyopathy[J].Clin Cardiol,2014,37(4):222-226.
[31] Nerheim P,Birger-Botkin S,Piracha L,et al.Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia[J].Circulation,2004,110(3):247-252.
[32] Elkayam U,Tummala PP,Rao K,et al.Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy[J].N Engl J Med,2001,344(21):1567-1571.
[33] Savarese G,Vedin O,D'Amario D,et al.Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure[J].JACC Heart Fail,2019,7(4):306-317.
[34] de Groote P,Fertin M,Duva PA,et al.Long-term functional and clinical follow-up of patients with heart failure with recovered left ventricular ejection fraction after beta-blocker therapy[J].Circ Heart Fail,2014,7(3):434-439.
-
计量
- 文章访问数: 294
- PDF下载数: 44
- 施引文献: 0
下载: